Mucormycosis – India

July 15, 2021 – 45,432 cases of black fungus reported. 21,085 cases are under medical treatment. A total of 4,252 deaths have been recorded, and 84.4% of the cases had a diagnosis of COVID-19. The following types of mucormycosis identified in the source are ranked in highest to lowest percentages. Rhinocerebral (77.6%), Cutaneous (4.3%), and Pulmonary (3%).

According to the source, mucormycosis is an opportunistic infectious disease that is classified as fungal. It is caused by a mold that can cause fungal infection. Those with weak immune systems are more susceptible to the infection. Symptoms described in the source include: fever, pain, redness around the eye or nose, coughing, headache, and altered mental status.

Officials state that a detailed advisory will be in place to manage and treat COVID-Related myocormysis and to monitor Amphotericin-B injection distribution and availability.

Photo: Mucor fungus species.

Mucormycosis is a fungal infection. Generally, species in the Mucor, Rhizopus, Absidia, and Cunninghamella genera are most often implicated.

Common sources of infections are from soil and damp walls on old buildings.

It can infect the sinuses and brain, lungs, skin and digestive tract. The infection in some cases also spreads through the bloodstream where it can result in the formation of blood clots and tissue death in the surrounding areas. Patients with this disease frequently need amputations due to necrotized tissue when blood clots form.

Mostly mucormycosis occurs with underlying conditions such as diabetes, HIV, lymphomas kidney failure and immunosuppressive therapy. However, in some cases infection is reported without any predisposing factors present.

It has been reported in association with COVID-19 and may be caused by treatment with corticosteroids.

It is a very rare infection. Hospital outbreaks are a risk where infection can spread through contaminated hospital linen.

<<< Back to alert index

Follow us

While you are here, help us with

Access to Essential Drugs

One third of children, women and men have no access to essential medicines, putting lives at risk. Hospitals frequently run out of medicines and other essential supplies. Our Med-Aid program connects hospitals with aid and ensures that they receive exactly what they need.

Access to Diagnostics

Much of today’s innovation is either not reaching or not suitable for people in developing countries.

Data to Improve Health

Faster and reactive systems to help provide lifesaving support to vulnerable communities.

Support our work. It only takes a minute but makes a world of difference!

With your help we can bring modern diagnostics and essential medicines to people in need, track disease outbreaks better and help prevent future pandemics.